Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 469.34
   
  • Change Today:
    $-8.79
  • 52 Week High: $513.76
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,097,554
  • Market Cap: $110,760m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 469.34
Change Today $ -8.79
% Change -1.84 %
52 Week High $513.76
52 Week Low $374.46
Volume 1,097,554
Shares Issued 235.99m
Market Cap $110,760m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Mar-2026

Time Volume / Share Price
15:59 80 @ $469.35
15:59 61 @ $469.10
15:59 84 @ $469.10
15:59 101 @ $469.45
15:59 92 @ $469.27

Top of Page